Genocea Biosciences Inc Watch

from 10-K 35 pages Portions of This Exhibit Have Been Redacted Because They Are Both (I) Not Material and (II) Would Likely Cause Competitive Harm if Publicly Disclosed. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark [* * *]. Loan and Security Agreement

from 8-K 5 pages First Amendment to Amended and Restated Loan and Security Agreement

from 10-K 5 pages Second Amendment to Loan and Security Agreement

from 10-K 5 pages Second Amendment to Loan and Security Agreement

from 8-K 13 pages First Amendment to Loan and Security Agreement and Waivers

from 8-K 7 pages For Good and Valuable Consideration, the Receipt and Sufficiency of Which Are Hereby Acknowledged by Genocea Biosciences, Inc., a Delaware Corporation (The “Company”), the Company and Hercules Technology Growth Capital, Inc., a Maryland Corporation, in Its Capacity Under and Pursuant to the Loan Agreement (As Defined Below) as Administrative Agent for Itself and the Lender (As Defined in the Loan Agreement) (“Hercules”), Hereto Enter Into This Letter (The “Letter”) and Agree to the Following: 1. Initial Equity Investment

from S-1 24 pages Loan and Security Agreement No. V13111

from DRS 24 pages Loan and Security Agreement No. V13111